The paper, Utility of a multiple serum biomarker test to monitor remission status and relapse in dogs with lymphoma undergoing treatment with chemothe
Latest from the network
Looking for something specific?
The paper, Utility of a multiple serum biomarker test to monitor remission status and relapse in dogs with lymphoma undergoing treatment with chemothe
Further investment in the company’s dedicated Training and Validation Centre enhances Inca’s ability to support its customers and distributors, plus offers an expanded business development resource within the R&D department and accelerates Inca’s strategy to develop its inkjet technology
CEGX is a rapidly growing company focused on developing innovative methods and technologies to revolutionize the fields of epigenetics and personalized medicine.
The funding from Atlas Venture, Novartis Venture Fund, SR One, SV Life Sciences and Astellas Venture will enable Bicycle to continue its drug development programmes and to advance new drug candidates to clinical development for use in oncology.
The transaction, which is expected to complete early in 2015, covers all of the assets of Clariant’s Energy Storage business including its manufacturing facility in Candiac, Quebec, an R&D centre and pilot plant in Moosburg, Germany together with the customer order book and a substantial
Capturing ES cells is like stopping the developmental clock at the precise moment before they begin to turn into distinct cells and tissues
- Austin Smith